(60 days)
No
The description focuses on standard image processing techniques like quantification of mean pixel values, comparison with existing scans, calculation of uptake ratios, and subtraction. While "automated analysis" is mentioned, the context describes rule-based or algorithmic processes rather than AI/ML. The modifications also describe algorithmic changes (deformable registration) and database management, not AI/ML integration. There is no mention of AI, ML, or related terms like deep learning or neural networks.
No
The device aids clinicians in assessment and quantification of pathologies from scans, but it does not directly treat or modify a patient's condition.
Yes
The Scenium display and analysis software aids the clinician in the assessment and quantification of pathologies from PET and SPECT scans, and helps in the assessment of human brain scans by providing automated analysis and comparison with existing scans, which are all characteristics of a diagnostic device.
Yes
The device is explicitly described as "Scenium display and analysis software" and "Scenium VD10 display and analysis software," with the description focusing solely on software functionalities and workflows. It is intended to be run on existing commercially available software platforms or scanners, indicating it is a software component rather than a standalone hardware device.
Based on the provided text, the Scenium display and analysis software is not an In Vitro Diagnostic (IVD).
Here's why:
- IVDs analyze samples taken from the human body. The Scenium software analyzes images of the human brain obtained from PET and SPECT scans. These images are a representation of the physiological processes within the body, not a direct analysis of a biological sample like blood, urine, or tissue.
- The intended use is to aid the clinician in the assessment and quantification of pathologies from scans. This focuses on image analysis and comparison, not on performing tests on biological specimens.
- The device description details software workflows for image processing and analysis. It describes features like visualization, rendering, database comparison, ratio analysis, and subtraction of image data.
- There is no mention of analyzing biological samples or performing tests on them.
The Scenium software falls under the category of medical imaging software that assists clinicians in interpreting and analyzing medical images. While it provides quantitative data derived from the images, this is distinct from the analysis of biological samples that defines an IVD.
N/A
Intended Use / Indications for Use
The Scenium display and analysis software has been developed to aid the Clinician in the assessment and quantification of pathologies taken from PET and SPECT scans.
The software is deployed via medical imaging workplaces and is organized as a series of workflows which are specific to use with particular drug and disease combinations.
The software aids in the assessment of human brain scans enabling automated analysis through quantification of mean pixel values located within standard regions of interest. It facilitates comparison with existing scans derived from FDG-PET, amyloid-PET, and SPECT studies, calculation of uptake ratios between regions of interest, and subtraction between two functional scans.
Product codes (comma separated list FDA assigned to the subject device)
LLZ, KPS
Device Description
Scenium VD10 display and analysis software enables visualization and appropriate rendering of multimodality data, providing a number of features which enable the user to process acquired image data.
Scenium VD10 consists of three workflows:
- . Database Comparison
- Ratio Analysis ●
- Subtraction
These workflows are used to assist the clinician with the visual evaluation, assessment and quantification of pathologies with different imaging agents, such as using Amyloid imaging agents for dementia and Alzheimer's Disease, DaTSCAN(1-123) for Parkinson's Disease and FDG-PET for epileptic seizures.
The modifications made to the Scenium VD10 software (K133654) to create the Scenium VD20 software include:
- Customized databases can now be imported and exported in the Database Comparison . workflow.
- Three new FDG databases normalized to the region of the cerebellum, in addition to whole ● brain, were added to the Database Comparison workflow.
- . Deformable Registration for Amyloid PET has been integrated in the Ratio Analysis workflow with a different algorithm.
- . Launch performance decreased the time taken to display patient data in the Ratio Analysis workflow.
This change is based on current commercially available software features and does not change the technological characteristics of the device.
Scenium VD20 Analysis software is intended to be run on commercially available software platforms such as the Siemens syngo.MI Workflow software platform (K133644) or commercially available Siemens scanners (e.g. symbia Intevo (K142006), Biograph mCT (K123737).
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
PET, SPECT
Anatomical Site
human brain
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Clinician, medical imaging workplaces
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Risk Management has been ensured via risk analyses in compliance with ISO 14971;2012 to identify and provide mitigation to potential hazards beginning early in the design cycle and continuing throughout the development of the product. Siemens Medical Solutions, USA Inc. adheres to recognized and established industry standards for development including ISO 13485 and IEC 62304.
Verification and Validation activities have been successfully performed on the software package, including assurance that functions work as designed, performance requirements and specifications have been met, and that all hazard mitigations have been fully implemented. All testing has met the predetermined acceptance values.
Traceability of the requirements specified in the requirement specifications and functional specifications is ensured during component integration, software validation and system testing.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.2050 Medical image management and processing system.
(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an abstract image of a stylized eagle or bird-like figure, composed of three human profiles facing to the right. The profiles are stacked on top of each other, creating the shape of the bird.
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
March 29, 2015
Siemens Medical Solutions USA, Inc. % Ms. Alaine Medio PET and PCS Regulatory Projects Manager 810 Innovation Drive KNOXVILLE TN 37932
Re: K150192
Trade/Device Name: Scenium Regulation Number: 21 CFR 892.2050 Regulation Name: Picture Archiving And Communications System Regulatory Class: II Product Code: LLZ, KPS Dated: March 5, 2015 Received: March 9, 2015
Dear Ms. Medio:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
1
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours.
Michael D'Hara
for
Robert Ochs, Ph.D. Acting Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known)
K150192
Device Name Scenium VD20 Software
Indications for Use (Describe)
The Scenium display and analysis software has been developed to aid the Clinician in the assessment and quantification of pathologies taken from PET and SPECT scans.
The software is deployed via medical imaging workplaces and is organized as a series of workflows which are specific to use with particular drug and disease combinations.
The software aids in the assessment of human brain scans enabling automated analysis through quantification of mean pixel values located within standard regions of interest. It facilitates comparison with existing scans derived from FDG-PET, amyloid-PET, and SPECT studies, calculation of uptake ratios between regions of interest, and subtraction between two functional scans.
| Type of Use (Select one or both, as applicable) | |||
|---|---|---|---|
X Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
510(k) Summary
as required by 21 CFR Part 807.87(h)
Identification of the Submitter
| Identification of the Submitter | |
|---|---|
| Submitter: | Siemens Medical Solutions USA, Inc. |
| Molecular Imaging | |
| 810 Innovation Drive | |
| Knoxville, TN 37932 | |
| Primary Contact: | M. Alaine Medio, RAC |
| PET and PCS Regulatory | |
| Projects Manager | |
| Siemens Medical Solutions | |
| USA, Inc. | |
| Molecular Imaging | |
| 810 Innovation Drive | |
| Knoxville, TN 37932 | |
| Alternate Contact: | Veronica Padharia |
| Regulatory Affairs Specialist | |
| Siemens Medical Solutions | |
| USA, Inc. | |
| Molecular Imaging | |
| 2501 Barrington Road | |
| Hoffman Estates, IL 60192 | |
| Telephone Number: | (865) 218-2703 |
| (630) 877-5761 | |
| Fax Number: | (865) 218-3019 |
| (847) 304-6023 | |
| Name / Address of Manufacturer | Siemens Medical Solutions USA, Inc |
| Molecular Imaging | |
| 2501 N. Barrington Road | |
| Hoffman Estates, IL 60192 | |
| USA | |
| Date of Submission: | January 27, 2015 |
| Identification of the product | |
| Device Proprietary Name: | Scenium VD20 |
| Common Name: | Image Processing Software |
| Classification Name: | Picture Archiving and Communication System |
| per 21 CFR 892.2050 | |
| Product Code: | LLZ & KPS |
| Classification Panel: | Radiology |
| Device Class: | Class II |
4
Marketed Devices to which Equivalence is claimed
| Device | Manufacturer | 510(k) Number |
|---|---|---|
| Scenium VD10 | Siemens Medical Solutions USA, Inc | K133654 (February 28, 2014) |
Device Description:
Scenium VD10 display and analysis software enables visualization and appropriate rendering of multimodality data, providing a number of features which enable the user to process acquired image data.
Scenium VD10 consists of three workflows:
- . Database Comparison
- Ratio Analysis ●
- Subtraction
These workflows are used to assist the clinician with the visual evaluation, assessment and quantification of pathologies with different imaging agents, such as using Amyloid imaging agents for dementia and Alzheimer's Disease, DaTSCAN(1-123) for Parkinson's Disease and FDG-PET for epileptic seizures.
The modifications made to the Scenium VD10 software (K133654) to create the Scenium VD20 software include:
- Customized databases can now be imported and exported in the Database Comparison . workflow.
- Three new FDG databases normalized to the region of the cerebellum, in addition to whole ● brain, were added to the Database Comparison workflow.
- . Deformable Registration for Amyloid PET has been integrated in the Ratio Analysis workflow with a different algorithm.
- . Launch performance decreased the time taken to display patient data in the Ratio Analysis workflow.
This change is based on current commercially available software features and does not change the technological characteristics of the device.
Scenium VD20 Analysis software is intended to be run on commercially available software platforms such as the Siemens syngo.MI Workflow software platform (K133644) or commercially available Siemens scanners (e.g. symbia Intevo (K142006), Biograph mCT (K123737).
Indications for Use:
The Scenium display and analysis software has been developed to aid the Clinician in the assessment and quantification of pathologies taken from PET and SPECT scans.
The software is deployed via medical imaging workplaces and is organized as a series of workflows which are specific to use with particular drug and disease combinations.
The software aids in the assessment of human brain scans enabling automated analysis through quantification of mean pixel values located within standard regions of interest. It facilitates
5
comparison with existing scans derived from FDG-PET, amyloid-PET, and SPECT studies, calculation of uptake ratios between regions of interest, and subtraction between two functional scans.
Technological Characteristics
The Scenium VD20 software modifications are based on the commercially available Scenium VD10 software (K133654). The features introduced into Scenium VD20 had no impact on the technological characteristics already present in the commercially available predicate system.
Performance Testing / Safety and Effectiveness:
Risk Management has been ensured via risk analyses in compliance with ISO 14971;2012 to identify and provide mitigation to potential hazards beginning early in the design cycle and continuing throughout the development of the product. Siemens Medical Solutions, USA Inc. adheres to recognized and established industry standards for development including ISO 13485 and IEC 62304.
Verification and Validation activities have been successfully performed on the software package, including assurance that functions work as designed, performance requirements and specifications have been met, and that all hazard mitigations have been fully implemented. All testing has met the predetermined acceptance values.
Traceability of the requirements specified in the requirement specifications and functional specifications is ensured during component integration, software validation and system testing.
The device labeling contains instructions for use and any necessary cautions and warnings to provide for safe and effective use of the device.
The device is designed and manufactured in accordance with Quality System Regulations as outlined in 21 CFR 820.
Statement Regarding Substantial Equivalence:
There are no differences in the Indications for Use or Fundamental Technological Characteristics of the Scenium VD20 software as compared to the currently commercially available Scenium VD10 software (K133654). Both devices are used to assist the Clinician with the visual evaluation, assessment and quantification of pathologies derived from brain scans.
Additionally, there have been no changes that raise any new issues of safety and effectiveness as compared to the predicate device. Based on this information, as well as the documentation in support of the modifications, it is Siemens' opinion that the Scenium VD20 software with the modifications outlined in this application is substantially equivalent to the predicate device.